NeurologyNon-dopamine Parkinson's pill trims daily OFF time in a big trial
In the phase 3 ARISE trial, once-daily solengepras cut daily OFF time by 0.61 hours against placebo and improved daily function, alertness and quality of life.
6 October 2026